
Sign up to save your podcasts
Or


As COVID-19 spreads globally, populations who survive their illness will become immune. Mayo Vaccine Research Group Director Gregory Poland, MD, discusses antibody responses, duration of immunity, vaccine safety, and the prospects for using convalescent serum to passively immunize people unexposed to SARS-CoV-2.
By JAMA Network4.3
106106 ratings
As COVID-19 spreads globally, populations who survive their illness will become immune. Mayo Vaccine Research Group Director Gregory Poland, MD, discusses antibody responses, duration of immunity, vaccine safety, and the prospects for using convalescent serum to passively immunize people unexposed to SARS-CoV-2.

501 Listeners

162 Listeners

38 Listeners

21 Listeners

13 Listeners

11 Listeners

10 Listeners

16 Listeners

20 Listeners

5 Listeners

6 Listeners

30 Listeners

9 Listeners

90 Listeners

14 Listeners

5 Listeners

5 Listeners

18 Listeners

2 Listeners